Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

💊 Pharmaceuticals

💻 Telehealth

Location

Hong Kong

Market Cap

USD 18.80 B

Share Price

USD 38.01

Avg Daily Volume

700,338

Change (1 day)

-40.00%

Change (1 year)

850.25%

Change (YTD)

669.43%

Regencell Bioscience Holdings Limited Total Liabilities for the year ending June 30, 2024

Regencell Bioscience Holdings Limited Total Liabilities is NA for the year ending June 30, 2024. Total liabilities are the total amount of a company's debts and other obligations.

Regencell Bioscience Holdings Limited Total Liabilities for the year ending June 30, 2023 was USD 632.32 K, a -32.59% change year over year.
Regencell Bioscience Holdings Limited Total Liabilities for the year ending June 30, 2022 was USD 938.03 K.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables

NasdaqCM: RGC

Regencell Bioscience Holdings Limited

CEO	Mr. Yat-Gai Au
IPO Date	July 16, 2021
Location	Hong Kong
Headquarters	First Commercial Building
Employees	12
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 💊 Pharmaceuticals 💻 Telehealth

Description

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Similar companies

Novo Nordisk A/S

USD 73.32

-2.33%

AbbVie Inc.

USD 185.30

-0.10%

Roche Holding AG

USD 336.78

-0.52%

Abbott Laboratories

USD 132.99

0.44%

Novartis AG

USD 115.96

-0.50%

AstraZeneca PLC

USD 140.24

-1.30%

Merck & Co., Inc.

USD 79.06

-0.29%

Amgen Inc.

USD 289.33

-0.10%

Pfizer Inc.

USD 23.97

0.38%

Gilead Sciences, Inc.

USD 108.50

0.46%

Sanofi

USD 95.88

0.36%

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

Bristol-Myers Squibb Company

USD 46.86

0.04%

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK plc

USD 18.89

-2.25%

CSL Limited

USD 154.82

0.08%

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB SA

USD 181.46

0.14%

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

Bayer AG

USD 30.75

-0.65%

Celltrion, Inc.

USD 117.76

1.81%

WuXi AppTec Co., Ltd.

USD 9.39

0.82%

Laboratory Corporation of America Holdings

USD 261.88

0.19%

Hansoh Pharmaceutical Group Company Limited

USD 3.57

0.90%

Royalty Pharma plc

USD 34.86

-0.14%

Insmed Incorporated

USD 102.68

3.24%

Biogen Inc.

USD 127.04

0.40%

Astellas Pharma Inc.

USD 9.25

-0.70%

Innovent Biologics, Inc.

USD 9.90

-0.96%

Summit Therapeutics Inc.

USD 20.56

1.98%

Shionogi & Co., Ltd.

USD 17.12

0.25%

Genmab A/S

USD 212.20

-1.53%

Neurocrine Biosciences, Inc.

USD 126.55

-0.60%

Torrent Pharmaceuticals Limited

USD 36.56

0.20%

Exelixis, Inc.

USD 40.37

-0.91%

Mankind Pharma Limited

USD 26.42

-1.47%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.66

2.02%

BioMarin Pharmaceutical Inc.

USD 55.00

-0.43%

Ascendis Pharma A/S

USD 176.90

3.63%

Akeso, Inc.

USD 11.63

-0.81%

Lupin Limited

USD 22.49

0.94%

Huadong Medicine Co., Ltd

USD 5.79

1.13%

Ipsen S.A.

USD 116.25

-0.06%

Swedish Orphan Biovitrum AB (publ)

USD 28.19

-3.10%

Kyowa Kirin Co., Ltd.

USD 16.98

-0.29%

StockViz Staff

June 23, 2025

Any question? Send us an email